ES cells without teratomas by Tuma, Rabiya
 
In This Issue
 
JCB • VOLUME 167 • NUMBER 1 • 2004 578
 
Transport if loaded
 
uclear transporters can be viewed as
taxis that move cargo across the nuclear
envelope. On page 649, Plafker et al.
report that importin-11, a nuclear transport re-
ceptor, may be an especially selective cabbie.
Importin-11 transports UbcM2, a ubiquitin (Ub)-
conjugating enzyme, but it does so only when the
enzyme is charged with a Ub at its active site.
UbcM2 is an E2 enzyme, which works with
E1 and E3 proteins to polyubiquitinate and tag
proteins for degradation in the proteasome. To
test whether importin-11 preferentially transports
the Ub-charged UbcM2 or the unloaded enzyme,
Plafker et al. performed coimmunoprecipitation
assays with wild-type UbcM2, a mutant enzyme
that is constitutively loaded with Ub, or a mutant
that cannot be loaded. Importin-11 selectively
bound the Ub-charged forms of UbcM2. Further-
more, in vitro pull-down assays showed that, if
ATP or the E1 enzyme that loads Ub onto the
UbcM2 active site were depleted, importin-11 did
not bind UbcM2. In cell assays, catalytically
inactive UbcM2 failed to localize to the nucleus.
Only a subset of E2 enzymes bound to
importin-11. This specific interaction may control
the enzyme’s access to potential substrates,
including some involved in cell cycle progression.
Plus, if importin-11 gobbles up all the Ub-charged
UbcM2, then the enzyme cannot ubiquitinate
cytoplasmic proteins. 
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ES cells without teratomas
 
herapeutic use of embryonic stem cells may be hampered by their
proclivity to form pluripotent tumors called teratomas. On page
723, Bieberich et al. describe the use of a ceramide analogue, S18,
to induce apoptosis in a subpopulation of embryoid body–derived stem cells
(EBCs). Cells that survive the treatment express the neural marker nestin
and differentiate into neural progenitors when injected into the brains of
young mice. They do not form teratomas.
The S18 selectively affects those EBCs that express prostate apoptosis
response-4 (PAR-4) protein, an endogenous inhibitor of atypical PKC
 
 
 
.
Significantly, the majority of the PAR-4–expressing cells also express
Oct-4, a marker for pluripotency. Almost all Oct-4
 
 
 
 cells were positive
for PAR-4, suggesting that teratoma formation might be prevented via
elimination of PAR-4-expressing cells with ceramide-induced apoptosis
before injection into animals. Sure enough, after injection into the brains of
mice, treated cells differentiated into neural cells and some benign tumors,
T
 
but no invasive tumors. Un-
treated cells gave rise to a
significant number of terato-
mas in the same animals.
Bieberich et al. hypoth-
esize that coexpression of
Oct-4 and PAR-4 may indi-
cate that the expression of
PAR-4 is specifically up-reg-
ulated at particular stages dur-
ing ES cell differentiation.
Discovering the function and
mechanism behind this up-
regulation is the next task the
team plans to tackle.  Ceramide leaves stem cells free to form neurons.
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Mitochondria move in on calcium
 
itochondria aren’t just ATP factories.
They serve as important components in
intracellular signaling by modulating
Ca
 
2
 
 
 
 and act as a relay system in apoptosis. And they
are dynamic organelles, moving about the cell at a
rapid pace. On page 661, Yi et al. integrate these
observations by demonstrating that local Ca
 
2
 
 
 
 con-
centration controls mitochondrial movement.
Initially, the team was focused on the local
interactions between the endoplasmic reticulum (ER)
and mitochondria in myoblast cells in culture, but
then noticed that changes in Ca
 
2
 
 
 
 induced massive
fluctuations in the rate of mitochondrial movement.
To quantify these changes, the team labeled mito-
chondria with YFP fused to a mitochondrial target-
ing sequence. Stimulating the cells with vasopressin,
a Ca
 
2
 
 
 
 mobilizing hormone, or inducing localized
Ca
 
2
 
 
 
 release from the ER using IP
 
3
 
, they found that
the mitochondria move most at resting Ca
 
2
 
 
 
 concen-
M
Mitochondria (red) stop motoring 
along microtubules when they 
meet high Ca
2 .
 
trations. The organelles came to a standstill
when they reached a region with a high
concentration of Ca
 
2
 
 
 
 (1–2 
 
 
 
M range) and
moved again as the Ca
 
2
 
 
 
 levels went down.
The mitochondria appear to move along
microtubules, yet neither of the known micro-
tubule motors are Ca
 
2
 
 
 
-dependent. The team
hypothesizes that myosin Va, which binds
calmodulin and is probably regulated by Ca
 
2
 
 
 
,
acts as a bridge between the microtubule mo-
tors and the mitochondria. They are currently
testing the idea by down-regulating myosin Va.
Mitochondrial arrest in regions of high Ca
 
2
 
 
 
 makes biological sense.
The organelles would enhance the cell’s local Ca
 
2
 
 
 
 buffering ability by soaking
up the cation. In addition, Ca
 
2
 
 
 
 stimulates ATP production in the mitochondria,
so the Ca
 
2
 
 
 
 influx would induce a local rise in ATP that could be used to drive
ATP-dependent Ca
 
2
 
 
 
 pumps in the ER and the plasma membrane. Together,
the system would help speed the clearance of Ca
 
2
 
 
 
, allowing for rapid, short
signaling cascades. 
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